Timothy J. Barberich - 18 Dec 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Director
Signature: /s/ Timothy Barberich
Issuer symbol: TCRX
Transactions as of: 18 Dec 2023
Net transactions value: +$142,456
Form type: 4
Filing time: 21 Dec 2023, 17:00:47 UTC
Previous filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCRX	Voting Common Stock	Purchase	$140,881	+28,830	+76%	$4.89	66,710	18 Dec 2023	Direct	F1
transaction	TCRX	Voting Common Stock	Purchase	$1,575	+317	+0.48%	$4.97	67,027	19 Dec 2023	Direct
holding	TCRX	Voting Common Stock						33,259	18 Dec 2023	By Barberich Family Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.63 to $5.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2	These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.63 to $5.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.